COL10A1 and neoplasm: Intratumoral administration of miR-101-3p modified human primary BM-MSC EVs in BALB/c nude mice with SCC resulted in a decrease in COL10A1 expression, with a consequent reduction of tumor volume and weight and the invasion, migration and colony-forming ability of the cells [48].